BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 04/09/2012

FDA Clears Path for ALOXI (Palonosetron Hydrochloride) Capsules

The FDA has determined that ALOXI capsules, 0.5mg, were not withdrawn due to safety or effectiveness concerns, paving the way for potential approval of generic versions.

Source: Federal Register — Food and Drug AdministrationOpen original release →